Although the anti-NMDAR encephalitis patients usually required longer hospital stays, they showed no significant difference in the complete recovery rate and recurrence rate from the MOG-AD or autoimmune GFAP-A patients (p<0.05). The gene discussed is GFAP; the disease is Alzheimer disease.